CoChat

Analysis of Antidepressant-like Effects and Action Mechanisms of GSB-106, a Small Molecule, Affecting the TrkB Signaling

Open access
Vakhitova, Yulia V., Kalinina, Tatiana S., Zainullina, Liana F., Lusta, Anastasiya Yu., Volkova, Anna V., Kudryashov, Nikita V., Gudasheva, Tatiana A., Shimshirt, Alexander A., Kadnikov, Ilya A., Voronin, Mikhail V., Seredenin, Sergei B. · 2021 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Abstract

Induction of BDNF-TrkB signaling is associated with the action mechanisms of conventional and fast-acting antidepressants. GSB-106, developed as a small dimeric dipeptide mimetic of BDNF, was previously shown to produce antidepressant-like effects in the mouse Porsolt test, tail suspension test, Nomura water wheel test, in the chronic social defeat stress model and in the inflammation-induced model of depression. In the present study, we evaluated the effect of chronic per os administration of GSB-106 to Balb/c mice under unpredictable chronic mild stress (UCMS). It was observed for the first time that long term GSB-106 treatment (1 mg/kg, 26 days) during ongoing UCMS procedure ameliorated the depressive-like behaviors in mice as indicated by the Porsolt test. In addition, chronic per os administration of GSB-106 resulted in an increase in BDNF levels, which were found to be decreased in the prefrontal cortex and hippocampus of mice after UCMS. Furthermore, prolonged GSB-106 treatment was accompanied by an increase in the content of pTrkB706/707 in the prefrontal cortex and by a pronounced increase in the level of pTrkB816 in both studied brain structures of mice subjected to UCMS procedure. In summary, the present data show that chronic GSB-106 treatment produces an antidepressant-like effect in the unpredictable chronic mild stress model, which is likely to be associated with the regulation of the BDNF-TrkB signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms222413381

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Chemical structure of GSB-106.
Figure 1 Chemical structure of GSB-106.CC BY · PubMed Central
Figure 2 Schedule of unpredictable chronic mild stress experiment. Mice were exposed to UCMS for 28 days, after which, GSB-106 or vehicle were administered over (a) 14 days (14 sequential per os treatments, 1 time per day) or (b) 26 days (26 sequential per os treatments, 1 time per day) during the ongoing stress.
Figure 2 Schedule of unpredictable chronic mild stress experiment. Mice were exposed to UCMS for 28 days, after which, GSB-106 or vehicle were administered over (a) 14 days (14 sequential per os treatments, 1 time per day) or (b) 26 days (26 sequential per os treatments, 1 time per day) during the ongoing stress.CC BY · PubMed Central
Figure 3 Effect of GSB-106 (0.1 or 1 mg/kg, 14 per os treatments) on the depressive-like behavior of mice in the Porsolt test. The results are presented as means ± SEM. The significance of intergroup differences was estimated by one-way analysis of the variance (ANOVA), followed by Tukey’s multiple comparisons test.
Figure 3 Effect of GSB-106 (0.1 or 1 mg/kg, 14 per os treatments) on the depressive-like behavior of mice in the Porsolt test. The results are presented as means ± SEM. The significance of intergroup differences was estimated by one-way analysis of the variance (ANOVA), followed by Tukey’s multiple comparisons test.CC BY · PubMed Central
Figure 4 GSB-106 (1 mg/kg, 26 per os treatments) attenuates depressive-like behavior of mice in the Porsolt test. The results are presented as means ± SEM. The significance of intergroup differences was estimated by one-way analysis of the variance (ANOVA), followed by Tukey’s multiple comparisons test.
Figure 4 GSB-106 (1 mg/kg, 26 per os treatments) attenuates depressive-like behavior of mice in the Porsolt test. The results are presented as means ± SEM. The significance of intergroup differences was estimated by one-way analysis of the variance (ANOVA), followed by Tukey’s multiple comparisons test.CC BY · PubMed Central
Figure 5 The effect of GSB-106 on the BDNF content and the site-specific phosphorylation of TrkB receptor in the prefrontal cortex and the hippocampus of mice subjected to UCMS. (a) BDNF, (b) pTrkB(Tyr706/707), (c) pTrkB(Tyr816), (d) pTrkB(Tyr515) proteins expression in mice prefrontal cortex and hippocampus. After the completion of UCMS procedure and the compound treatment, mice were decapitated and brain structures were collected. Protein extracts were subjected to polyacrylamide gel electrophoresis and transferred for Western blotting. Blots were probed with anti-BDNF, anti-phosphorylated TrkB antibodies and then reprobed with anti-TrkB antibody, anti-a-tubulin antibodies. For every picture, representative images for immunoblots are shown on the top panels, and quantitative data are shown on the bottom panels (red dots on the graphs correspond to mice 4, 8, 10 and 15; dark dots are all mice samples in the group). All data are expressed as mean ± SEM (n = 3; the significance of intergroup differences was estimated by one-way analysis of the variance (ANOVA), followed by Tukey’s multiple comparisons test).
Figure 5 The effect of GSB-106 on the BDNF content and the site-specific phosphorylation of TrkB receptor in the prefrontal cortex and the hippocampus of mice subjected to UCMS. (a) BDNF, (b) pTrkB(Tyr706/707), (c) pTrkB(Tyr816), (d) pTrkB(Tyr515) proteins expression in mice prefrontal cortex and hippocampus. After the completion of UCMS procedure and the compound treatment, mice were decapitated and brain structures were collected. Protein extracts were subjected to polyacrylamide gel electrophoresis and transferred for Western blotting. Blots were probed with anti-BDNF, anti-phosphorylated TrkB antibodies and then reprobed with anti-TrkB antibody, anti-a-tubulin antibodies. For every picture, representative images for immunoblots are shown on the top panels, and quantitative data are shown on the bottom panels (red dots on the graphs correspond to mice 4, 8, 10 and 15; dark dots are all mice samples in the group). All data are expressed as mean ± SEM (n = 3; the significance of intergroup differences was estimated by one-way analysis of the variance (ANOVA), followed by Tukey’s multiple comparisons test).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 88 references

Cited by

See all 21

Metadata

Authors
Vakhitova, Y. V., Kalinina, T. S., Zainullina, L. F., Lusta, A. Y., Volkova, A. V., Kudryashov, N. V., Gudasheva, T. A., Shimshirt, A. A., Kadnikov, I. A., Voronin, M. V., & Seredenin, S. B.
Affiliations
  • Institute of Pharmacology Russian Academy of Medical Sciences (RU)
  • Department of Psychopharmacology, FSBI “Zakusov Institute of Pharmacology”, Baltiyskaya Street 8, 125315 Moscow, Russia
  • Department of Pharmacogenetics, FSBI “Zakusov Institute of Pharmacology”, Baltiyskaya Street 8, 125315 Moscow, Russia
  • Department of Medicinal Chemistry, FSBI “Zakusov Institute of Pharmacology”, Baltiyskaya Street 8, 125315 Moscow, Russia
Corresponding author
Vakhitova, Yulia V.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-12-13
Volume
22
Issue
24
Pages
13381
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4200538075
Cited by
21
References
88
Citations by year
2026: 2 · 2025: 2 · 2024: 7 · 2023: 5 · 2022: 5
FWCI
2.48
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministry of Science and Higher Education of the Russian Federation (Project 0521-2019-0002)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
antidepressant-like effects, BDNF/TrkB signaling, TrkB phosphorylation, BDNF mimetic, chronic unpredictable mild stress, depression, prefrontal cortex, hippocampus, rapid-acting antidepressants
MeSH terms
Animals, Antidepressive Agents, Brain, Dipeptides, Hippocampus, Male, Membrane Glycoproteins, Mice, Inbred BALB C, Protein-Tyrosine Kinases, Stress, Psychological, Signal Transduction, Prefrontal Cortex, Brain-Derived Neurotrophic Factor, Receptor, trkB, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of Antidepressant-like Effects and Action Mechanisms of GSB-106, a Small Molecule, Affecting the TrkB Signaling. https://app.cochat.ai/papers/10.3390/ijms222413381
The paper
Vakhitova, Y. V., Kalinina, T. S., Zainullina, L. F., Lusta, A. Y., Volkova, A. V., Kudryashov, N. V., Gudasheva, T. A., Shimshirt, A. A., Kadnikov, I. A., Voronin, M. V., & Seredenin, S. B. (2021). Analysis of Antidepressant-like Effects and Action Mechanisms of GSB-106, a Small Molecule, Affecting the TrkB Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms222413381

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.